Flash News: OKX Wallet Now Supports Bitlayer, a Bitcoin Layer 2 Network Based on BitVM
SINGAPORE, May 7, 2024 /PRNewswire/ -- OKX, a leading Web3 technology company, has issued updates for May 7, 2024.
OKX Wallet Now Supports Bitlayer, a Bitcoin Layer 2 Network Based on BitVM
OKX Wallet now supports Bitlayer, a Bitcoin Layer 2 network based on BitVM. This integration underlines OKX's continuous commitment to driving innovation and accessibility in the blockchain ecosystem.
By supporting Bitlayer, OKX Wallet now offers its users the ability to view and transfer assets on the Bitlayer mainnet. Users can also explore dApps belonging to the Bitlayer ecosystem on Discover, OKX Wallet's portal that gathers thousands of dApps, DEXs, blockchain games, NFTs and supplementary tools.
Bitlayer is the first Bitcoin Layer 2 network based on BitVM, offering Bitcoin-equivalent security and Turing completeness. The protocol aims to build a more scalable and interconnected Bitcoin ecosystem, addressing challenges in scalability and the limitation of smart contracts that have previously hindered Bitcoin's ecosystem development.
A leading global technology company driving the future of Web3, OKX provides a comprehensive suite of products to meet the needs of beginners and experts alike.
To learn more about OKX, download our app or visit:okx.com
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024).
The campaign focuses on access to IBD care and treatment as the burden of...
The global industrial automation market in life sciences industry size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.4% during the forecast period. ...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...